Potential roles of zinc in the pathophysiology and treatment of major depressive disorder

  title={Potential roles of zinc in the pathophysiology and treatment of major depressive disorder},
  author={Walter Swardfager and Nathan Herrmann and Roger S. McIntyre and Graham Mazereeuw and Kyle W Goldberger and Danielle S Cha and Yael Schwartz and Krista L. Lanct{\^o}t},
  journal={Neuroscience \& Biobehavioral Reviews},

Figures and Tables from this paper

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges
A review of MDD and its association with inflammation, mitochondrial dysfunction, and oxidative stress is provided and is aimed at thoroughly discussing the putative links between these events, which may contribute to the design and development of new therapeutic approaches for patients.
Nutritional strategies for dealing with depression.
This review will focus on the main nutrients, phytochemicals and food that have been shown to have beneficial effects against depression.
The Role of Zinc in Mood Disorders
Mood disorders have many forms, from anxiety attacks, depression, Obsessive Compulsive Disorder (OCD) to Post Traumatic Disorder (PTSD). Recently, many studies have shown that zinc may act as a
Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option
Mechanisms of antidepressant resistance
Depression is one of the most frequent and severe mental disorder. Since the discovery of antidepressant (AD) properties of the imipramine and then after of other tricyclic compounds, several classes
Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression
A robust effect of zinc is indicated in reversing behavioral alteration induced by CUS in mice, through a possible modulation of the glutamatergic neurotransmission, extending literature data regarding the mechanisms underlying its antidepressant-like action.
Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims.


Zinc and depression. An update.
All the data indicate the important role of zinc homeostasis in psychopathology and therapy of depression and potential clinical antidepressant activity of this ion.
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.
The currently available knowledge regarding the role of the glutamatergic system in the etiopathogenesis of mood disorders and putative glutamate modulators is reviewed.
The role of the hippocampus in the pathophysiology of major depression.
Data from imaging studies suggest both structural changes in the volume of the HC and functional alterations in frontotemporal and limbic circuits that may be critical for mood regulation in patients with MDD.
Zinc Signaling in the Hippocampus and Its Relation to Pathogenesis of Depression
It is summarized that hippocampal Zn2+ signaling serves to maintain healthy brain and that glucocorticoid signaling, which is responsive to zinc homeostasis in the living body, is linked to the pathophysiology of depression.
Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems
The hippocampal formation contains a high concentration of corticoid receptors and undergoes plastic modifications, including decreased neurogenesis and cellular remodelling, following stress exposure, and various major neurotransmitter systems in the hippocampus are involved in these effects.
Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex
Examination of the effect of chronic zinc, citalopram and imipramine intraperitoneal administration on the presynaptic and extracellular zinc concentration in the rat prefrontal cortex and hippocampus suggests the involvement of this biometal presyaptic/synaptic homeostasis in the antidepressant mechanism(s).
Epigenetics of the Depressed Brain: Role of Histone Acetylation and Methylation
Recent advances in understanding of epigenetic contributions to depression, in particular the role of histone acetylation and methylation, are revealed, revealing novel mechanistic insight into the syndrome that may aid in the development of novel targets for depression treatment.
Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
The results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders, and propose that disturbances in glutamate-mediated synaptic transmission in the medial temporal lobe are important factors in the pathophysiology of these severe psychiatric illnesses.
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Repeated Unpredictable Stress and Antidepressants Differentially Regulate Expression of the Bcl-2 Family of Apoptotic Genes in Rat Cortical, Hippocampal, and Limbic Brain Structures
The selective regulation of Bcl-xl and Bax in hippocampal subfields and of B cl-2 in the Cg cortex, amygdala, and hypothalamus suggests that these cellular adaptations contribute to the long-term neural plastic adaptations to stress and ADTs in cortical, hypothalamic, and limbic brain structures.